Organic compounds -- part of the class 532-570 series inventions 05/09

20090137807 - Electrochromic material with improved lifetime: Disclosed are viologen derivatives as an electrochromic material having improved stability and lifetime, a metal oxide electrode including the same, and an electrochromic device using the viologen derivative as an electrochromic material. The viologen derivative includes a suitable regulator group capable of increasing ΔE that is a potential difference between... Agent: Mckenna Long & Aldridge LLP

20090137808 - Process for manufacturing bisphosphonic acids: A manufacturing process for the preparation of bisphosphonic acids and in particular zoledronic acid is provided wherein diglyme, monoglyme, or a mixture thereof, is utilized to produce a homogenous, water soluble, solid reaction mass that upon cooling, dissolving in water and stripping results in a high purity product and comparatively... Agent: Albemarle Corporation Patent Department

20090137809 - Demethylation of 14 hydroxy substituted alkaloid derivatives: The present invention is directed to a method for demethylating 14-hydroxy substituted alkaloid derivatives, in particular of 14-hydroxy-17-methyl-4,5-epoxymorphinane-6-on-derivatives. This is achieved by reacting a starting compound with a compound of general formula R1OOC—N═N—COOR2 in a suitable solvent.... Agent: The Nath Law Group

20090137810 - Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders: e

20090137811 - Process for the preparation of donepezil and intermediate compounds thereof as well as hydrates of donepezil: The present invention relates to a new process for the preparation of intermediate compounds useful in the manufacture of donepezil, or a pharmaceutically-acceptable salt thereof, and also relates to processes for preparing donepezil and to the novel intermediates per se. In addition the invention relates to various hydrated forms of... Agent: Foley & Lardner LLP

20090137812 - Process for producing 1-benzyl-4-[5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine or its salt thereof via novel intermediate: Disclosed herein the process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2yl)methyl]piperidine or its salt thereof employing novel intermediates.... Agent: Workman Nydegger 1000 Eagle Gate Tower

20090137813 - Process for production of carebastine: Processes are disclosed for preparing piperidine derivative compounds of the formulae I, II or III:... Agent: Heslin Rothenberg Farley & Mesiti PC

20090137814 - Synthesis of diaminodinitropyridine: A process for the preparation of diaminodinitropyridine or diaminodinitrobenzene by contacting an aminopyridine or aminobenzene with oleum and nitric acid, wherein the improvement comprises adding at least about 1% molar excess of nitric acid, based upon the aminopyridine or aminobenzene, with stirring for at least two hours to form first... Agent: E I Du Pont De Nemours And Company Legal Patent Records Center

20090131669 - Synthetic nanopores for dna sequencing: A compound and methods of making thereof having the structure shown below is disclosed. Each Ar is an aromatic group. Each M is palladium, platinum, or rhenium. At least one X in the compound has an aliphatic having at least 1 carbon atom. Each x, each y, and each z... Agent: Naval Research Laboratory Associate Counsel (patents)

20090131670 - Bis-triphenylsilyl compounds and their application on organic electronic device: c

20090131671 - Novel phosphonic acid compounds as inhibitors of serine proteases: The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.... Agent: Philip S. Johnson Johnson & Johnson

20090131672 - Synthesis of sodium narcistatin and related compounds: The present invention involves use of the compounds narciclasine (2a) and 7-deoxy-narciclasine (2c), which are obtained via isolation from the medicinal plant species Narcissus (Amaryllidaceae), as precursors in a novel synthesis method in which each of these compounds are selectively hydrogenated to produce trans-dihydronarciclasine (1a) and 7-deoxy-trans-dihydronarciclasine (1c). Also described... Agent: Fennemore Craig

20090131673 - Electroluminescent device: Disclosed are electroluminescent devices that comprise organic layers that contain dibenzofuran compounds. The compounds are suitable components of, for example, blue-emitting, durable, organo-electroluminescent layers. The electroluminescent devices may be employed for full color display panels in, for example, mobile phones, televisions and personal computer screens.... Agent: Joann Villamizar Ciba Corporation/patent Department

20090131674 - Polymide oligomers and their use: The present invention relates to polyamide oligomers with linear or branched chain structure with a number average molar mass of 800 to 5000 g/mol, with basic end groups which are at least partially NH2 end groups and carboxyl end groups, produced by condensation of polyamide-forming monomers, the concentration of NH2... Agent: Greenblum & Bernstein, P.L.C

20090131675 - Methods for structural analysis of proteins: The invention provides methods and compositions for protein structure analysis, including substrate binding sites, sites of protein-protein interactions, three dimensional structure analysis, and stability, all with single amino acid resolution. In general, the subject methods involve introduction of cysteine residues, which serve as probes for physical analysis, into a protein... Agent: Stanford University Office Of Technology Licensing Bozicevic, Field & Francis LLP

20090131676 - Pyrazole compounds and thrombopoietin receptor activators: A compound represented by the formula (I) (wherein R1, R2, R3 and R4 are as defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20090131677 - Substituted beta-phenyl-alpha-hydroxy-propanoic acid, synthesis method and use thereof: The present invention relates to a compound of the formula (I), wherein R1, R2 and R3 are each independently selected from H, OH, F, Cl, Br, methoxy and ethoxy; or alternatively, R1 and R2 together form —OCH2O—, R3 is selected from H, OH, methoxy, ethoxy and halogens; R4 is OH... Agent: Cantor Colburn, LLP

20090124805 - Method for synthesis of iriduim (iii) complexes with sterically demanding ligands: Phosphorescent materials and devices with improved device manufacturing, fabrication, stability, efficiency, and/or color.... Agent: Townsend And Townsend And Crew, LLP

20090124806 - Process for producing carboxylic acid from primary alcohol: o

20090124807 - Intermediate compounds useful to prepare dolasetron: The present invention relates to intermediates useful in the synthesis of Dolasetron and synthetic precursors thereof, as well as to processes for obtaining them. In addition, it refers to the hydrochloric salt of Dolasetron and polymorphic forms of Dolasetron and precursors thereof.... Agent: Moore & Van Allen PLLC

20090124808 - Process for preparing acyclic hcv protease inhibitors: e

20090124809 - Process for preparing acyclic hcv protease inhibitors:

20090124810 - Process for production of piperidine derivatives:

20090124811 - Method for resolving omeprazole salts: The present invention relates to the resolution by preferential crystallization of potassium salts of racemic omeprazole which is a solvate of ethanol and/or of ethylene glycol, which consists in converting the omeprazole to the potassium salt in the form of a solvate or of a mixture of these solvates in... Agent: Young & Thompson

20090118511 - New method for preparing tiotropium salts: P

20090118512 - Process for preparing 6,7-dihydro-5h-imidazo[1,5-a]pyridin-8-one: 6,7-Dihydro-5H-imidazo[1,5-a]pyridin-8-one (I), is obtainable in high yields by: 1) a process which proceeds from a suitably protected C-(3-hydroxypyridin-2-yl)methylamine whose amine is converted to the formamide which is then cyclized to the imidazo[1,5-a]pyridine and hydrogenated to the 6,7-dihydro-5H-imidazo[1,5-a]pyridin-8-one, and suitably protected C-(3-hydroxypyridin-2-yl)methylamines can be prepared either in 2 steps proceeding from... Agent: Wenderoth, Lind & Ponack, L.L.P.

20090118513 - Chemical compounds: 7

20090118514 - Processes for preparing pioglitazone and its pharmaceutically acceptable salts: An improved process for the preparation of pioglitazone and its pharmaceutically acceptable salts by reducing 5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzilidene]-2,4-thiazolidinedione with sodium borohydride in presence of a cobalt ion and dimethyl glyoxime. More particularly the cobalt ion used is cobalt chloride hexahydrate, or, cobalt (II) nitrate hexahydrate in presence of mixture of DMF and... Agent: Dr. Reddy''s Laboratories, Inc.

20090118515 - Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines: The present invention is directed to a process for preparing intermediates that are useful to prepare certain antibacterial N-formyl hydroxylamine compounds which are peptide deformylase inhibitors.... Agent: Lahive & Cockfield, LLP Floor 30, Suite 3000